2018
DOI: 10.1155/2018/9321643
|View full text |Cite
|
Sign up to set email alerts
|

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease

Abstract: The prevalence of nonalcoholic fatty liver disease and the consequent burden of metabolic syndrome have increased in recent years. Although the pathogenesis of nonalcoholic fatty liver disease is not completely understood, it is thought to be the hepatic manifestation of the dysregulation of insulin-dependent pathways leading to insulin resistance and adipose tissue accumulation in the liver. Recently, the gut-liver axis has been proposed as a key player in the pathogenesis of NAFLD, as the passage of bacteria… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
67
0
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 64 publications
(70 citation statements)
references
References 69 publications
2
67
0
1
Order By: Relevance
“…Dysbiosis plays a main role in increasing intestinal permeability, which permits passage of bacteria‐derived products such as LPS into the portal circulation. In addition to IBD, dysbiosis, intestinal permeability and the ensuing inflammation, has been associated with numerous diseases including NEC, allergies, nonalcoholic fatty liver disease (NAFLD), cardiovascular disease, rheumatoid arthritis, and numerous neurological disorders such as bipolar, schizophrenia, autism, and Parkinson's . Systemic inflammation was assessed using an inflammatory cytokine protein array that detects 40 different inflammatory cytokines.…”
Section: Resultsmentioning
confidence: 99%
“…Dysbiosis plays a main role in increasing intestinal permeability, which permits passage of bacteria‐derived products such as LPS into the portal circulation. In addition to IBD, dysbiosis, intestinal permeability and the ensuing inflammation, has been associated with numerous diseases including NEC, allergies, nonalcoholic fatty liver disease (NAFLD), cardiovascular disease, rheumatoid arthritis, and numerous neurological disorders such as bipolar, schizophrenia, autism, and Parkinson's . Systemic inflammation was assessed using an inflammatory cytokine protein array that detects 40 different inflammatory cytokines.…”
Section: Resultsmentioning
confidence: 99%
“…IRFs are recognized to work in the progression of NAFLD in addition to their original functions which are the regulation of the expression of type I IFN and IFN-induced genes. [145][146][147][148][149] In addition, short-chain fatty acids (SCFAs), including propionic, butyric and acetic acids, are the main products of carbohydrates digested by gut bacteria. IRF3 is proved to alleviate the lipid accumulation and to improve IR in the liver, and IRF9 can be used to ameliorate steatosis and inflammation.…”
Section: Inflammation and Innate Immunitymentioning
confidence: 99%
“…Gut dysbiosis exposes the liver to a large amount of pathogen‐associated molecular patterns (PAMPs): lipopolysaccharide, DNA, RNA and endotoxins. All of these activate TLRs on Kupffer cell surface and then the downstream myeloid differentiation primary response 88 (MyD88) signal, which ultimately lead to nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) transcription and expression of pro‐inflammatory cytokines and chemokines 57 . Alongside pro‐inflammatory response, TLR activation triggers a wide range of pathological processes ranging from inflammasome activation to apoptosis.…”
Section: Fatty Liver Disease: Crosstalk With Surrounding Tissuesmentioning
confidence: 99%